Clinical trial

North American Study for the Treatment of Refractory Ascites (NASTRA)

NCT00006166 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed

Key facts

NCT number NCT00006166
Title North American Study for the Treatment of Refractory Ascites (NASTRA)
Official title The North American Study for the Treatment of Refractory Ascites (NASTRA) Clinical Trial
Lead sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Ascites, Liver Cirrhosis
Intervention type Procedure
Interventions Transjugular intrahepatic portasystemic shunts (TIPS), Total paracentecis (TP)
Start date Mar 1, 1997
Completion Oct 1, 2001
First posted Aug 9, 2000
Last update posted Jan 13, 2010
Countries Canada, United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies